Omkar Pharmachem Stock Price Today (NSE: 532167)
Fundamental Score
Omkar Pharmachem Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Omkar Pharmachem share price today is ₹7.60, up +0.00% on NSE/BSE as of 17 September 2026. Omkar Pharmachem (532167) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of ₹7.67 (Cr). The 52-week high for 532167 share price is ₹29.74 and the 52-week low is ₹11.02. At a P/E ratio of 91.91x, 532167 is currently trading above its industry average P/E of 22.30x. The company has a Return on Equity (ROE) of 0.52% and a debt-to-equity ratio of 0.00.
Omkar Pharmachem Share Price Chart — NSE/BSE Historical Performance
Omkar Pharmachem share price chart: -28.83% return over the past month. 52-week high ₹29.74, 52-week low ₹11.02.
Omkar Pharmachem — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹11.83 | ₹11.83 | ₹11.60 | ₹11.60 | 456.00 (Cr) | |
| ₹11.60 | ₹11.60 | ₹11.60 | ₹11.60 | 2.00 (Cr) | |
| ₹11.02 | ₹11.60 | ₹11.02 | ₹11.60 | 4.13K (Cr) | |
| ₹11.07 | ₹11.60 | ₹11.07 | ₹11.60 | 68.00 (Cr) | |
| ₹11.65 | ₹11.65 | ₹11.65 | ₹11.65 | 104.00 (Cr) | |
| ₹12.26 | ₹12.26 | ₹12.26 | ₹12.26 | 895.00 (Cr) | |
| ₹12.90 | ₹12.90 | ₹12.90 | ₹12.90 | 138.00 (Cr) | |
| ₹13.57 | ₹13.57 | ₹13.57 | ₹13.57 | 198.00 (Cr) | |
| ₹14.25 | ₹14.28 | ₹14.25 | ₹14.28 | 427.00 (Cr) | |
| ₹14.48 | ₹15.00 | ₹14.48 | ₹15.00 | 2.34K (Cr) |
Omkar Pharmachem — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹16.75 | ₹17.58 | ₹11.02 | ₹11.60 | -30.75% | |
| ₹20.80 | ₹20.80 | ₹15.00 | ₹16.75 | -19.47% | |
| ₹27.00 | ₹27.00 | ₹17.33 | ₹19.82 | -26.59% | |
| ₹28.03 | ₹28.31 | ₹27.00 | ₹27.00 | -3.67% | |
| ₹29.50 | ₹29.50 | ₹28.03 | ₹28.03 | -4.98% | |
| ₹29.50 | ₹29.50 | ₹29.50 | ₹29.50 | +0.00% | |
| ₹29.74 | ₹29.74 | ₹29.50 | ₹29.50 | -0.81% | |
| ₹29.74 | ₹29.74 | ₹29.74 | ₹29.74 | +0.00% | |
| ₹28.33 | ₹29.74 | ₹28.33 | ₹29.74 | +4.98% | |
| ₹28.33 | ₹28.33 | ₹28.33 | ₹28.33 | +0.00% | |
| ₹25.50 | ₹28.33 | ₹25.50 | ₹28.33 | +11.10% | |
| ₹25.56 | ₹26.83 | ₹25.50 | ₹25.50 | -0.23% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Omkar Pharmachem Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Omkar Pharmachem Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 532167 across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (50.95%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (78.52x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 5.96)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (0.52%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.72%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 91.91x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-137.59%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-35.71%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-11.42% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-11.42% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Low Promoter Commitment (0.03%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Omkar Pharmachem vs Commodity Chemicals Peers
Peer Comparison - Commodity Chemicals
Compare Omkar Pharmachem with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
19.1/100 | ₹7.60₹8 | ₹7.67₹7.67 | 91.91Average 91.9 Average | 0.52%Poor 0.52% Poor | 0.72%Poor 0.72% Poor | 0.00Excellent 0.0 Excellent | -11.42%Poor -11.42% Poor | 11.72%Good 11.72% Good | 0.00% | |
SRF LimitedSRF Limited... SRF • 503806 | 49.2/100 | ₹2520.00₹2520 | ₹74697.84₹74697.84 | 34.55Average 34.6 Average | 0.00%Poor 0.00% Poor | 15.29%Good 15.29% Good | 0.36Excellent 0.4 Excellent | 9.70%Good 9.70% Good | 13.45%Good 13.45% Good | 0.32% |
Deepak Fertilizers and Petrochemicals Corporation LimitedDeepak Fertiliz... DEEPAKFERT • 500645 | 34.6/100 | ₹1357.80₹1358 | ₹17140.87₹17140.87 | 17.42Average 17.4 Average | 11.27%Average 11.27% Average | 12.57%Average 12.57% Average | 0.80Good 0.8 Good | 12.99%Good 12.99% Good | 14.65%Good 14.65% Good | 0.65% |
Tata Chemicals LimitedTata Chemicals ... TATACHEM • 500770 | 16.3/100 | ₹603.05₹603 | ₹15377.77₹15377.77 | — — | -8.86%Poor -8.86% Poor | -3.24%Poor -3.24% Poor | 0.38Excellent 0.4 Excellent | 2.85%Average 2.85% Average | 7.41%Good 7.41% Good | 1.58% |
56.5/100 | ₹574.60₹575 | ₹8446.62₹8446.62 | 8.15Average 8.1 Average | 0.00%Poor 0.00% Poor | 10.62%Average 10.62% Average | 0.00Excellent 0.0 Excellent | 3.00%Average 3.00% Average | 8.67%Good 8.67% Good | 3.61% | |
Tanfac Industries LtdTanfac Industri... TANFACIND • 506854 | 56/100 | ₹3513.80₹3514 | ₹7010.03₹7010.03 | 103.64Average 103.6 Average | 20.47%Excellent 20.47% Excellent | 27.28%Excellent 27.28% Excellent | 0.25Excellent 0.2 Excellent | 32.34%Excellent 32.34% Excellent | 36.90%Excellent 36.90% Excellent | 0.18% |
Gujarat Alkalies and Chemicals LimitedGujarat Alkalie... GUJALKALI • 530001 | 32.9/100 | ₹712.55₹713 | ₹5232.97₹5232.97 | 78.82Average 78.8 Average | 0.00%Poor 0.00% Poor | 1.58%Poor 1.58% Poor | 0.11Excellent 0.1 Excellent | — — | 12.40%Good 12.40% Good | 2.66% |
GHCL LimitedGHCL Limited... GHCL • 500171 | 38.9/100 | ₹426.30₹426 | ₹3927.50₹3927.50 | 7.65Average 7.6 Average | 13.42%Average 13.42% Average | 16.97%Good 16.97% Good | 0.02Excellent 0.0 Excellent | 7.70%Good 7.70% Good | 1.11%Average 1.11% Average | 2.75% |
Grauer & Weil India LimitedGrauer & Weil I... GRAUWEIL • 505710 | 67.5/100 | ₹72.67₹73 | ₹3609.71₹3609.71 | 22.01Average 22.0 Average | 16.23%Good 16.23% Good | 21.35%Excellent 21.35% Excellent | 0.01Excellent 0.0 Excellent | 19.92%Excellent 19.92% Excellent | 14.48%Good 14.48% Good | 0.63% |
Chemplast Sanmar LimitedChemplast Sanma... CHEMPLASTS • 543336 | 18.4/100 | ₹176.88₹177 | ₹2796.83₹2796.83 | — — | 0.00%Poor 0.00% Poor | -3.82%Poor -3.82% Poor | 1.11Average 1.1 Average | — — | 2.14%Average 2.14% Average | 0.00% |
J.G.Chemicals LimitedJ.G.Chemicals L... JGCHEM • 544138 | 66.7/100 | ₹619.50₹620 | ₹2427.57₹2427.57 | 32.30Average 32.3 Average | 13.27%Average 13.27% Average | 21.98%Excellent 21.98% Excellent | 0.01Excellent 0.0 Excellent | 23.80%Excellent 23.80% Excellent | 17.52%Excellent 17.52% Excellent | 0.23% |
Top Commodity Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
Omkar Pharmachem Quarterly Performance
Latest quarterly metrics for 532167 — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-35.71%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-137.59%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
11.72%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-11.42%
Compounded annual net profit growth over 5 years
Omkar Pharmachem Technical Indicators
SMA 50, SMA 200, RSI and volume signals for 532167 — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Omkar Pharmachem Financial Statements
Annual income statement, balance sheet and cash flow for Omkar Pharmachem (532167) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Omkar Pharmachem
About 532167 (Omkar Pharmachem)
Omkar Pharmachem (532167) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Commodity Chemicals sector with a cur...rent market capitalisation of ₹7.67 (Cr). Omkar Pharmachem has delivered a Return on Equity (ROE) of 0.52% and a ROCE of 0.72%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking 532167 share price can monitor key metrics including P/E ratio, promoter holding of 0.03%, and quarterly earnings growth.
Company Details
532167 Share Price: Frequently Asked Questions
What is the current share price of Omkar Pharmachem?
Omkar Pharmachem (532167) trades at ₹7.60 on BSE. Market cap ₹7.67 (Cr). Educational data only.
What is the P/E ratio of Omkar Pharmachem?
Omkar Pharmachem has a P/E of 91.91x vs industry average 22.30x.
What is the Bull Run score for Omkar Pharmachem?
Omkar Pharmachem has a Bull Run score of 19.1/100 based on 25+ financial parameters.
Does Omkar Pharmachem pay dividends?
Omkar Pharmachem has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Omkar Pharmachem?
Omkar Pharmachem has ROE of 0.52%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Omkar Pharmachem?
Omkar Pharmachem has debt-to-equity of 0.00.
Is Omkar Pharmachem a good investment?
Bull Run gives Omkar Pharmachem a score of 19.1/100. This is not investment advice — consult a SEBI-registered advisor.